[an error occurred while processing the directive]
RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Ministry of Health of the Republic of Bashkortostan

Company

Assets

Owners

+ Ministry of Health of the Republic of Bashkortostan

History

2023: Former department chief - Accused in preferential drug write-off case

The ex-head of the department for organizing pharmaceutical activities and drug support of the Ministry of Health of Bashkiria, 44-year-old Svetlana Khusainova, is accused of negligence, resulting in particularly large damage (part 1.1 of article 293 of the Criminal Code of the Russian Federation). The criminal case was initiated on the basis of the materials of the prosecutor's check, the press service of the regional prosecutor's office reported on April 27, 2023. Read more here.

2022

Airat Rakhmatullin - Minister of Health of Bashkortostan

At the end of May 2022, by decree of the head of the Republic of Bashkortostan, Radiy Khabirov, Airat Rakhmatullin, who had previously worked as the head physician of the Ufa City Clinical Hospital (GKB) No. 18, was appointed Minister of Health of the region. He also worked as a leading expert of the department for organizing medical care for the adult population of the Ministry of Health of Bashkiria, the chief specialist of the department for project activities. Read more here.

The Deputy Minister of Health of Bashkiria was searched in the case of the purchase of drugs 10 times higher than the required volume

At the end of April 2022, in Ufa, security forces searched the Deputy Minister of Health of Bashkiria Irina Kononova as part of a criminal case on violations in the purchase of a vital drug. Read more here.

Azat Rakhmatullin - the new head of the Ministry of Health of the Republic of Bashkortostan

At the end of March 2022, it became known about the appointment of Azat Rakhmatullin as head of the Ministry of Health of the Republic of Bashkortostan. Prior to that, she served for a long time as the first deputy head of the regional department.

Maxim Zabelin, who previously headed the Ministry of Health of the Republic of Bashkortostan, moved to the post of head of the administration of the head of the republic. Read more here.

2021: FAS revealed violations in the purchase of 5 CT scanners by the Ministry of Health of Bashkortostan for 412 million rubles

In February 2021, the Department of the Federal Antimonopoly Service (FAS) in the Republic of Bashkortostan reported violations committed by the regional Ministry of Health when supplying medical equipment within the framework of the national project "Healthcare." Read more here.

2019: SK: Bashkiria Ministry of Health purchased 10 times more cancer drugs than required

In mid-April 2022, the Investigation Department of the Investigative Committee of the Russian Federation for the Republic of Bashkortostan announced the initiation of a criminal case under Part 1 of Art. 286 of the Criminal Code of the Russian Federation (abuse of office) in connection with the revealed violations in the procurement of cancer drugs by the regional Ministry of Health.

According to the investigation, in 2019, the Ministry of Health of the Republic of Bashkortostan purchased the drug Triptorelin, included in the list of vital and essential drugs, in the amount of more than 3.7 thousand packages for a total amount of over 51 million rubles. At the same time, in violation of the requirements of the legislation in the field of procurement of goods to meet state and municipal needs, the amount of the purchased drug exceeded about 10 times the real need for the specified drug to provide patients in medical institutions of the republic.

The Ministry of Health of Bashkiria for the year purchased 10 times more cancer drugs than required

As a result, 1,670 packages of the drug with a total value of more than 10 million rubles have expired, thereby causing damage to the budget of the republic by the above amount, the regional IC said in a statement.

They also reported that by mid-April 2022, investigators organized a set of investigative actions aimed at establishing all the circumstances and causes of the identified violations, as well as the persons who committed them. The progress and results of the investigation are under the control of the leadership of the investigative department of the republic.

Drugs with the international non-proprietary name "Tryptorelin" are registered in Russia with Pharmstandard-UfaVITA (Tryptorelin-long), French Ipsen (Diferelin) and German Ferring (Decapeptil).

The Federal Compulsory Medical Insurance Fund in April 2022 presented data on violations in the write-off of chemotherapy drugs. The total amount of dubious transactions, which cannot be confirmed, in 2021 amounted to 185.9 million rubles.[1]

Notes